a stage one clinical trial on an oral antiviral therapy that a Covid-19 patient could take when they first develop symptoms, which would make it the first oral antiviral treatment for coronavirus. ... [+]
Pfizer has been working with the company Biontech on the development of a Covid 19 vaccine. Photo: Christophe Gateau/dpa The trial is being conducted in the U.S. and relies on protease inhibitors—the same kind ofThe trial is randomized and includes placebo groups with both single and multiple-dose studies.
The company is also studying an intravenous antiviral to treat Covid-19, which is now being used on clinical trial patients hospitalized with Covid-19. “Together, the two [oral and intravenous antivirals] have the potential to create an end to end treatment paradigm that complements vaccination,” Pfizer chief scientific officer Mikael Dolsten said.
Thanks Obama ! You rock.
Helpful, since getting a COVID19 vaccine is impossible. So many categories for being eligible to receive a COVID19 vaccine is impossible to be vaccinated.
Thought $VXRT was first? Vaxart said its vaccine is the only oral tablet in the U.S. to be tested in humans.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: Forbes - 🏆 394. / 53 더 많은 것을 읽으십시오 »
출처: Forbes - 🏆 394. / 53 더 많은 것을 읽으십시오 »
출처: Forbes - 🏆 394. / 53 더 많은 것을 읽으십시오 »